Piper Sandler lowered the firm’s price target on CVS Health (CVS) to $64 from $72 and keeps an Overweight rating on the shares. The firm believes CVS has multiple, viable paths to 100-200 bps of ...

TD Cowen upgraded shares of CVS Health from a “hold” rating to a “buy” rating and lifted their target price for the company from $59.00 to $85.00 in a research report on Friday, October 4th.

TD Cowen analyst Charles Rhyee raised the firm’s price target on CVS Health (CVS) to $80 from $73 and keeps a Buy rating on the shares. The firm said it remains a Best Idea for 2025 and while a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TD Cowen raised CVS Health from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $59.00 to $85.00 in a research note on Friday, October 4th.

CVS), and UnitedHealth Group (NYSE:UNH) have sued the Federal Trade Commission, arguing that a case the agency has filed against them regarding inflated insulin prices is unconstitutional.